The World’s Only Bioprosthetic Auto-regulated Artificial Heart: From Total Artificial Heart (TAH) to Physiologic Heart Replacement Therapy (PHRT)

Project Information

Aeson®

Grant agreement ID: 190185733

DOI

10.3030/190185733

Project closed

EC signature date 6 April 2023

Start date 1 October 2022

End date 30 June 2025

Funded under

• The European Innovation Council (EIC)

Total cost

€ 11 560 168,75

EU contribution

€ 2 500 000,00

Coordinated by

CARMAT
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (3)

The total artificial heart: An existential transformation beyond technology

Author(s): Anne‐Céline Martin, Bernard Cholley
Published in: European Journal of Heart Failure, Issue 27, 2025, ISSN 1388-9842
Publisher: Wiley
DOI: 10.1002/EJHF.3592

Prehabilitation Using a Cardiac Rehabilitation Program for a Patient With a Total Artificial Heart Prior to Heart Transplantation

Author(s): Michaël Racodon, Éric Hermand, Jean-Michel Lemahieu, Pauline Blairon, Pierre Vanhove, Amandine Secq
Published in: Journal of Cardiopulmonary Rehabilitation and Prevention, Issue 44, 2025, ISSN 1932-7501
Publisher: Ovid Technologies (Wolters Kluwer Health)
DOI: 10.1097/HCR.0000000000000842

Implantation Technique for the Aeson Total Artificial Heart

Author(s): André Vincentelli, Yuriy Pya, Ivan Netuka, Assad Haneya, Jan Schmitto, Michel Kindo, Peter Wearden, Piet Jansen, Christian Latremouille
Published in: Operative Techniques in Thoracic and Cardiovascular Surgery, Issue 29, 2024, ISSN 1522-2942
Publisher: Elsevier BV
DOI: 10.1053/J.OPTECHSTCVS.2024.01.002

Other (4)

The First Auto-regulated Total Artificial Heart Implant in the United States

Author(s): Schroder JN, McCartney SL, Jansen P, et al
Published in: 2022
Publisher: Annals of Thoracic Surgery Short Report
DOI: 10.1016/j.atssr.2022.09.007

CARMAT: the first experience with the Aeson bioprosthetic total artificial heart as a bridge to transplantation in a case of post-infarction ventricular septal rupture

Author(s): Huenges K, Panholzer B, Cremer J and Haneya A
Published in: 2023
Publisher: Frontiers in Cardiovascular medicine
DOI: 10.3389/fcvm.2023.1211365

Intermediate-dose prophylactic anticoagulation with Low Molecular Weight Heparin is safe after Bioprosthetic artificial heart implantation

Author(s): Smadja DM, Ivak P, Pya Y, et al.
Published in: 2022
Publisher: J Heart Lung Transplantation
DOI: 10.1016/j.healun.2022.05.017

Bioprosthetic Total Artificial Heart Implantation does not induce chronic inflammation

Author(s): Peronino C, Guerin CL, Ivak P, et al.
Published in: 2022
Publisher: ASAIO Journal
DOI: 10.1097/MAT.0000000000001820